School Of Medicine Basic Sciences

It started with a hacksaw and a multimillion-dollar instrument. Richard Caprioli, then a postdoctoral fellow, was given the saw to cut the instrument in half during his first day of his postdoctoral studies. It was the day that Caprioli, now Stanford Moore Professor of Biochemistry, developed a desire to “do innovative things” with mass spectrometry instruments.” This yearning resulted in him becoming a pioneer of new mass spec techniques, including imaging mass spec. Read More

Leader in the field of ribosome biogenesis, Katrin Karbstein has joined the School of Medicine Basic Sciences as Ingram Professor of Cancer Research and professor of biochemistry. Her work has revealed the intricate details of ribosome biogenesis and revealed how misassembled ribosomes contribute to disease. She is also a community leader and mentor to emerging scholars. Read More

New training grant supplement aims to enhance laboratory safety practices and promote a safety mindset among graduate students and lab leaders. Read More

The Russell G. Hamilton Graduate Leadership Institute, an initiative from the Vanderbilt University Graduate School, recognized over 130 students from the School of Medicine Basic Sciences with awards during the 2023–24 academic year. Read More

Using computer-aided drug design, the labs of Heidi Hamm, Jens Meiler, and Craig Lindsley generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read More

Tina Iverson, Louise B. McGavock Chair and Professor of pharmacology and biochemistry, will take the role of associate dean for faculty on July 1, 2024. Read More

By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read More

Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read More

New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read More

Meet Stephen Doster, ‪associate program director of academic and educational support‬ in Basic Sciences. Read More